Original Query: ALL
Previous Study | Return to List | Next Study

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01189942
Recruitment Status : Completed
First Posted : August 27, 2010
Last Update Posted : September 20, 2016
Novotech (Australia) Pty Limited
Information provided by (Responsible Party):
OncoMed Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2011
  Study Completion Date : February 2011